Target intelligence / Profile preview

HYI antisense RNA 1 (HYI-AS1)

Target
HYI-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Non-coding RNA
01

Overview

HYI antisense RNA 1 (HYI-AS1) is a long non-coding RNA (lncRNA) gene transcribed in the antisense orientation relative to the HYI gene, and is classified as a non-protein coding transcript. Long non-coding RNAs, including antisense RNAs such as HYI-AS1, are recognized for their regulatory roles in gene expression, generally acting at the transcriptional or post-transcriptional level. HYI-AS1 is annotated without direct evidence of protein-coding capacity and does not belong to families such as receptors, enzymes, transporters, or transcription factors. Current literature and public gene databases do not indicate it is a primary or validated therapeutic target in the sense of drug development against the RNA itself, nor are there known drug interactions or established mechanisms of action for drugs via this RNA. Some gene-disease associations (e.g., with Maple Syrup Urine Disease) are suggested at a database level, but primary literature support is lacking and functions remain largely uncharacterized. Note: - HYI-AS1 should not be confused with HIF1A-AS1 (hypoxia-inducible factor 1 alpha antisense RNA 1), which is a different, biologically active lncRNA implicated in various diseases and cell biology contexts. - There is no evidence that HYI-AS1 is misspelled or a non-existent entity, but most of its molecular, biological, and disease roles are currently uncharacterized in the literature. If you are seeking information on the more widely studied HIF1A-AS1, please clarify, as these are distinct molecules with different biological functions and associations.

Other names
HYI-AS1HYI antisense RNA 1 (non-protein coding)
02

Biological functions

Regulation of gene expressionPost-transcriptional regulationPossible involvement in cellular metabolism and RNA transport (by analogy with related lncRNAs)
03

Disease associations

Potential association with Maple Syrup Urine DiseaseBy analogy to other lncRNAs, may have roles in cancer or metabolic disease, but no direct, validated role described in literature for this specific lncRNA

Beyond the preview

Go deeper on HYI antisense RNA 1 (HYI-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HYI antisense RNA 1 (HYI-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call